Saturday 17 October 2026 Export SPRY’s income statement to Excel — free account

ARS Pharmaceuticals, Inc.

ARS Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $84.3 million, down 5.46% from fiscal 2024. In the quarter to June 2026, revenue grew 114.2%, EPS fell 37.0%, free cash flow fell 53.7% and total debt rose 138.5%, each against the same quarter a year earlier.

4.02 0.05 −1.23%

Follow SPRY

Alert me

Market cap: $404.8M
P/E: 0.0×
Fwd P/E: −4.8×
Dividend yield: —
F-score: 1/9
Altman Z: 1.32
Beneish M: −0.44
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	0.00	0.00	0.00	0.00	+8 more quarters Free account
P/S ratio Full definition →	6.80	8.06	13.63	6.96
P/FCF ratio Full definition →	0.00	0.00	0.00	0.00
P/Operating CF Full definition →	(13.06)	(17.74)	(26.41)	(21.11)
P/B ratio Full definition →	63.58	13.01	10.05	6.73
Price to Tangible BV Full definition →	0.00	16.92	11.51	7.47
EV/Sales Full definition →	7.05	7.76	12.72	6.12
EV/EBITDA Full definition →	0.00	0.00	0.00	0.00
EV/Operating CF Full definition →	(4.19)	(4.39)	(6.28)	(10.23)
EV/FCF Full definition →	(3.88)	(4.03)	(5.75)	(10.16)
Quick Ratio Full definition →	3.13	4.63	6.91	6.38
Current Ratio Full definition →	3.48	4.94	7.28	6.66
Net Debt/EBITDA Full definition →	(0.45)	0.49	1.82	2.23
Debt/Assets Full definition →	68.78%	59.53%	51.43%	45.14%
Debt/Equity Full definition →	13.72	2.79	1.47	1.14
Asset Turnover Full definition →	0.42	0.32	0.25	0.48
Operating CF/Net income Full definition →	0.98	0.74	1.05	0.92
Capex/Depreciation Full definition →	0.00	0.00	3.41	8.64
Interest Coverage Full definition →	(24.79)	(24.64)	—	—
Research and Development Expense of Revenue Full definition →	13.96%	19.12%	12.26%	8.46%
Selling, General and Administrative Expense of Revenue Full definition →	230.49%	318.35%	213.46%	230.00%
Intangible Assets out of Total Assets Full definition →	0.06	0.05	0.04	0.04
Share Based Compensation of Revenue Full definition →	36.83%	32.73%	20.43%	17.50%
Graham Net Nets Full definition →	(0.03)	0.02	0.06	0.11
Graham Number Full definition →	0.00	0.00	0.00	0.00
Earnings Yield Full definition →	(27.22%)	(25.03%)	(15.02%)	(8.06%)
Free Cash Flow Yield Full definition →	(26.66%)	(23.93%)	(16.25%)	(8.66%)
Revenue per Share Full definition →	0.34	0.23	0.29	0.33
Operating CF per Share Full definition →	(0.61)	(0.45)	(0.44)	(0.48)
Capex per Share Full definition →	0.00	0.00	(0.02)	(0.06)
Free Cash Flow per Share Full definition →	(0.61)	(0.45)	(0.46)	(0.54)
Cash per Share Full definition →	1.45	2.02	2.49	2.92
Shareholders Equity per Share Full definition →	0.13	0.62	1.16	1.49
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	0.13	0.62	1.16	1.49
Free Cash Flow Full definition →	(60.93)	(44.95)	(45.48)	(53.10)
Working Capital Full definition →	150.65	195.62	245.75	287.99
Capital Expenditures Full definition →	—	—	(2.00)	(6.06)
Net Current Asset Value Full definition →	(25.47)	18.97	71.50	113.72
EV/EBIT Full definition →	0.00	0.00	0.00	0.00
Capex to Sales Full definition →	0.00	0.00	0.07	0.19
Price to Operating Income Full definition →	0.00	0.00	0.00	0.00
Other line items
Average Receivables Full definition →	35.98	18.98	16.76	18.61
Average Payables Full definition →	52.00	37.64	30.39	33.14
Average Inventory Full definition →	10.21	8.04	6.79	4.25
Average Assets Full definition →	281.48	307.44	339.40	295.20
Average Common Equity Full definition →	102.42	145.14	185.53	174.32

Show all line items

Columns are period end dates

Stockrow Weekly